A Study to Evaluate the Safety and Efficacy of ALMB-0168 in Patients With Osteosarcoma
Clinical trial NCT04886765 · UNKNOWN
Trial details
- NCT number
- NCT04886765
- Sponsor
- AlaMab Therapeutics (Shanghai) Inc.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-01
- Primary completion
- 2023-11-01
- Enrollment
- 238
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.